Get free PhD updates, every week | SIGN UP NOW Get free PhD updates, every week | SIGN UP NOW

We have 48 breast cancer PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


breast cancer PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships

We have 48 breast cancer PhD Projects, Programmes & Scholarships PhD Projects, Programmes & Scholarships

PhD saved successfully

Cancer: Understanding the immunosuppressive role of fibroblast and macrophages in Breast cancer

Oncolytic viruses (OVs) preferentially infect and kill cancer cells, and their clinical efficacy has been demonstrated against a number of different cancers. The most clinically advanced OV is a genetically engineered herpes simplex virus (T-VEC) which expresses GMCSF to aid the development of anti-tumour immune responses; T-VEC is approved for the treatment of metastatic melanoma. Read more

Cancer: Characterization of EGFR signaling activated by the endothelium in the process of breast cancer metastasis to the brain

The Epidermal Growth Factor Receptor (EGFR) is important in normal physiology regulating epithelial development and homeostasis. In cancer, deregulation resulting from mutation, amplification or transcriptional upregulation promotes tumorigenesis. Read more

MScR: Role of the Rho GTPase RhoD in breast cancer

Epithelial cancers such as breast cancer become difficult to treat when they invade the surrounding tissues, eventually entering the blood stream and spreading to other parts of the body to form metastases. Read more

Mechanisms of cancer cell invasion

Epithelial cancers such as breast cancer become difficult to treat when they invade the surrounding tissues, eventually entering the blood stream and spreading to other parts of the body to form metastases. Read more

Role of the Rho GTPase RhoD in cancer

Epithelial cancers such as breast cancer become difficult to treat when they invade the surrounding tissues, eventually entering the blood stream and spreading to other parts of the body to form metastases. Read more

Investigating the clinical and molecular significance of the microbiome in breast cancer

Breast Cancer (BC) is the most common cancer in the UK, accounting for 15% of new cancer cases. There is a significant unmet clinical need to understand why some cancers do not respond to treatment and what drives metastasis. Read more

Developing novel therapeutic strategies to better treat Triple Negative Breast Cancer

One in two people will develop cancer in their lifetime and it is a leading cause of death. While significant progress has been made in the treatment of some cancers, there still remain some forms of the disease with limited treatment options and poor outcome. Read more

Therapeutic modulation of radioiodine uptake in thyroid and breast cancer

We are seeking talented, motivated students with a passion for research in thyroid or breast cancer led by Professor Chris McCabe at the University of Birmingham (Professor Chris McCabe - Institute of Metabolism and Systems Research - University of Birmingham). Read more

Cancer Engineering : Bone metastases in breast cancer patients

  Research Group: School of Mechanical Engineering
Would you like to learn new skills in mechanical and medical engineering with a focus on multiscale bone biomechanics, 3D printing and advanced computational modelling ? Could you be a future research leader in providing solutions to some of Europe’s most pressing healthcare problems? Do you want to further your career at one of the UK’s leading research intensive universities?. Read more

Cancer: Repurposing drugs as new treatments for breast cancer

Breast cancer (BC) is the most common cancer, with over 1 million new cases diagnosed worldwide each year. For some types of BC, hormonal treatments have been very effective but one particular BC subtype, triple negative breast cancer (TNBC), is highly aggressive and lacks a targeted therapy. Read more

Assessing the molecular mechanisms by which Cathepsin V promotes breast cancer growth and metastasis

Targeted therapies such as tamoxifen, fulvestrant and anastrozole have exhibited significant clinical success since being introduced as treatments for Estrogen Receptor positive (ER+) breast cancer patients. Read more

Filtering Results